These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8437902)

  • 1. Immunosuppressive agents.
    Dannie E
    Nurs Times; 1993 Jan 27-Feb 2; 89(4):34-7. PubMed ID: 8437902
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation: immune system suppression and reconstitution.
    Alcoser PW; Burchett S
    Am J Nurs; 1999 Jun; 99(6):26-31; quiz 32. PubMed ID: 10489556
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin a: a new era in organ transplantation.
    DeBakey ME
    Compr Ther; 1984 Feb; 10(2):7-15. PubMed ID: 6368108
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential utility of statins as novel weapons against graft-versus-host disease.
    Namazi MR; Handjani F; Sodaifi M
    Med Hypotheses; 2005; 65(6):1203-4. PubMed ID: 16139438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inolimomab (OPi).
    Winkler M
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1464-7. PubMed ID: 12431019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New immunosuppressants in BMT/GVHD.
    Basara N; Günzelmann S; Willenbacher W; Fauser AA; Kiehl MG
    Transplant Proc; 2001 May; 33(3):2220-2. PubMed ID: 11377507
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppression and the problems in homologous bone marrow transplantation].
    Yabe H; Kato S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
    [No Abstract]   [Full Text] [Related]  

  • 9. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of graft-versus-host disease].
    Wiktor-Jedrzejczak W
    Acta Haematol Pol; 1987; 18(3-4):220-4. PubMed ID: 3330400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
    Basić-Jukić N; Labar B
    Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
    Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Hashino S; Kobayashi S; Noto S; Sakurada K; Asaka M
    Transplant Proc; 1996 Jun; 28(3):1746-7. PubMed ID: 8658865
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allogenic bone marrow transplantation complications. Part II].
    Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA
    Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transplantation. New immunosuppressive agents and new possibilities for combination therapy].
    Ohlman S; Gannedahl G; Ericzon BG; Groth CG
    Lakartidningen; 1992 Dec; 89(50):4347-9. PubMed ID: 1469964
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there an effective therapy for chronic graft-versus-host disease?
    Schiller G; Gale RP
    Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease.
    Tse JC; Moore TB
    Pharmacotherapy; 1998; 18(5):988-1000. PubMed ID: 9758310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow grafts and tolerance.
    Thomas ED
    Nature; 1986 Sep 11-17; 323(6084):110-1. PubMed ID: 3528864
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
    Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
    Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.